186 related articles for article (PubMed ID: 11602916)
1. [Systemic treatment of renal-cell carcinoma--present status].
Steiner T; Schubert J
Dtsch Med Wochenschr; 2001 Sep; 126(39):1080-4. PubMed ID: 11602916
[No Abstract] [Full Text] [Related]
2. [Are immunotherapy and chemotherapy in metastatic renal cell cancer out?].
Schmitz-Dräger BJ
Urologe A; 1992 Jul; 31(4):213-4. PubMed ID: 1514204
[No Abstract] [Full Text] [Related]
3. Immunotherapy for metastatic renal cell carcinoma.
Wirth MP
Urol Clin North Am; 1993 May; 20(2):283-95. PubMed ID: 7684167
[TBL] [Abstract][Full Text] [Related]
4. [Immunotherapy of metastatic renal cell cancer].
Manseck A; Wirth M
Urologe A; 1993 Sep; 32(5):360-73. PubMed ID: 7692655
[TBL] [Abstract][Full Text] [Related]
5. Systemic therapy of metastatic renal cell carcinoma.
Vugrin D
Semin Nephrol; 1987 Jun; 7(2):152-62. PubMed ID: 2442806
[No Abstract] [Full Text] [Related]
6. Can vaccination or tyrosine kinase inhibitor therapy play a role in the adjuvant treatment of renal cell carcinoma?
Brookman-May S; May M; Gilfrich C; Wieland WF; Burger M
Expert Rev Anticancer Ther; 2010 Jun; 10(6):813-23. PubMed ID: 20553207
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for metastatic renal cell carcinoma.
McDermott DF; Rini BI
BJU Int; 2007 May; 99(5 Pt B):1282-8. PubMed ID: 17441925
[No Abstract] [Full Text] [Related]
8. [Prognostic factors for predicting the success of immunotherapy in metastatic renal cell carcinoma].
Schmitz-Dräger BJ; Jankevicius F; Otto T
Urologe A; 1995 May; 34(3):195-9. PubMed ID: 7610511
[TBL] [Abstract][Full Text] [Related]
9. New therapeutic developments in renal cell cancer.
Prenen H; Gil T; Awada A
Crit Rev Oncol Hematol; 2009 Jan; 69(1):56-63. PubMed ID: 18752971
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy for renal cell carcinoma.
Jacobsohn KM; Wood CG
Semin Oncol; 2006 Oct; 33(5):576-82. PubMed ID: 17045086
[TBL] [Abstract][Full Text] [Related]
11. No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma?
Kwak C; Park YH; Jeong CW; Lee SE; Ku JH
Urol Oncol; 2007; 25(4):310-6. PubMed ID: 17628297
[TBL] [Abstract][Full Text] [Related]
12. [Carcinogenesis and immunobiology of tumors. Scientific and clinical aspects].
Granov AM; Molchanov OE
Vopr Onkol; 2008; 54(4):401-9. PubMed ID: 18942393
[No Abstract] [Full Text] [Related]
13. Metastatic renal cell carcinoma: systemic treatment.
Abi-Aad AS; deKernion JB
Acta Urol Belg; 1996 May; 64(2):3-8. PubMed ID: 8701805
[No Abstract] [Full Text] [Related]
14. Integrative tumor board: metastatic renal cell carcinoma: medical oncology.
Gupta SK; Vogelzang N
Integr Cancer Ther; 2004 Mar; 3(1):26-9. PubMed ID: 15035871
[No Abstract] [Full Text] [Related]
15. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
[TBL] [Abstract][Full Text] [Related]
16. Nonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma.
Nelson RP; Logan TF; Abonour R
Bone Marrow Transplant; 2002 Dec; 30(12):805-12. PubMed ID: 12476272
[TBL] [Abstract][Full Text] [Related]
17. Is cytotoxic chemotherapy effective in the treatment of advanced renal cell carcinoma?
Swanson DA
Semin Urol; 1993 Feb; 11(1):35-40. PubMed ID: 7682003
[No Abstract] [Full Text] [Related]
18. Interferon in metastatic renal cell carcinoma.
Fosså SD
Semin Oncol; 2000 Apr; 27(2):187-93. PubMed ID: 10768597
[TBL] [Abstract][Full Text] [Related]
19. Renal carcinoma (RC): regulation of antitumoral immune responses.
Heicappell R; Ackermann R
Prog Clin Biol Res; 1992; 378():207-16. PubMed ID: 1284503
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapeutic approaches for renal cancer.
Pizza G; de Vinci C; Viza D
Folia Biol (Praha); 2002; 48(5):167-81. PubMed ID: 12448765
[No Abstract] [Full Text] [Related]
[Next] [New Search]